Triumph Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
Triumph Capital Management's AGIO Position: Q3 2026 in Review
Triumph Capital Management held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 100 shares worth $3.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.
Triumph Capital Management first reported a position in AGIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.71K in Q2 2026. 241 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- Triumph Capital Management held 100 shares of Agios Pharmaceuticals worth $3.32K as of Q3 2026.
- Triumph Capital Management left its Agios Pharmaceuticals share count unchanged in Q3 2026.
- Agios Pharmaceuticals made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1512 holding.
- Triumph Capital Management first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Triumph Capital Management's Agios Pharmaceuticals position peaked at $3.71K in Q2 2026.
- 241 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.